Prostaglandin F2a (PGF2a): an inadequate marker of the vitality of wounds?

Int J Legal Med. 1994;106(6):312-4. doi: 10.1007/BF01224777.

Abstract

We have studied the viability of PGF2a as a vitality marker in skin wounds. Incised vital skin wounds and homolateral control pieces of skin were obtained from 20 autopsies performed at the Institute of Legal Medicine of Coimbra University (Portugal). We have also studied 10 fresh skin samples from the Department of Dermatology of the University Hospital (Granada). Our results show that PGF2a is not suitable for the diagnosis of the vitality of wounds because of its irregular behaviour.

Publication types

  • Clinical Trial
  • Controlled Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biomarkers
  • Dinoprost / analysis*
  • Dinoprost / metabolism
  • Humans
  • Postmortem Changes*
  • Radioimmunoassay
  • Reproducibility of Results
  • Time Factors
  • Wounds and Injuries / metabolism
  • Wounds and Injuries / pathology*

Substances

  • Biomarkers
  • Dinoprost